
About Hprime Labs Private Limited
Data last updated:
Hprime Labs Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 21 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85100UP2020PTC134930. Its GSTIN is 09AAFCH4522C1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Kumar Panigrahi and Dushyant Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 903 9th Floor Maxblis White House Sector – 75, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.05 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹1.25 Lakh (net margin -0.6%) and EBITDA of ₹3.43 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.
For more details, the company can be reached via its website hprimelabs.com.
Company details
Contact details
Hprime Labs Private Limited's registered office is in Noida, Uttar Pradesh. Its website is hprimelabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG – 903 9th Floor Maxblis White House Sector – 75, Noida, Uttar Pradesh, India – 201301
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Hprime Labs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hprime Labs is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Hprime Labs Private Limited, buy the company report.
Financials of Hprime Labs Private Limited
FY 2025 filings availableHprime Labs Private Limited reported revenue of ₹2.05 Cr (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 52% over three years, including 1% growth in the latest year. EBITDA fell 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.43 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹1.25 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.7% | |||
| Net Profit Margin | -0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Hprime Labs Private Limited, buy the company report.
Board of directors of Hprime Labs Private Limited
Hprime Labs has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Panigrahi | Director | 21 Sep 2020 | 6 Years 1 Months | Current |
| Dushyant Kumar | Director | 21 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Hprime Labs Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vista Speciality Diagnostics Private Limited | ₹2.06 Cr (FY 2025) | 40.0% | Hyderabad, Telangana, India | |||
| Hprime Labs Private Limitedthis company | ₹2.05 Cr (FY 2024) | -₹1.25 Lakh | -0.6% | 1.0% | Noida, Uttar Pradesh, India | |
| Ryt Digihealth Private Limited | ₹2.05 Cr (FY 2025) | -1.0% | Faridabad, Haryana, India | |||
| Dr Gunna's Healthcare Private Limited | ₹2.05 Cr (FY 2024) | 13189.0% | Hyderabad, Telangana, India | |||
| Centromed Labs Private Limited | ₹2.03 Cr (FY 2023) | Malakpet, Telangana, India |
To see the full peer comparison of Hprime Labs Private Limited, buy the company report.
Auditor
Hprime Labs Private Limited is audited by K MOHAN & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K MOHAN & CO. | FY 2022 | 025578C |
Shareholding
The shareholding of Hprime Labs Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Hprime Labs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hprime Labs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hprime Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hprime Labs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCH4522C1ZX | Uttar Pradesh | Active | 03 Oct 2020 |
To see the full GST registrations and return filing status of Hprime Labs Private Limited, buy the company report.
Recent activity
Hprime Labs Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Dushyant Kumar was appointed as Director on 21 Sep 2020.
Frequently asked questions
Hprime Labs is an active private limited company based in Noida, Uttar Pradesh, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 21 September 2020 (6+ years old) and is registered under CIN U85100UP2020PTC134930.
Hprime Labs has 2 current directors:
- Manoj Kumar Panigrahi - Director
- Dushyant Kumar - Director
The latest financial statements of Hprime Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Hprime Labs is 09AAFCH4522C1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Hprime Labs is U85100UP2020PTC134930. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hprime Labs was incorporated on 21 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Hprime Labs by revenue are Vista Speciality Diagnostics Private Limited, Ryt Digihealth Private Limited, Dr Gunna's Healthcare Private Limited, Centromed Labs Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Dushyant Kumar was appointed as Director on 21 Sep 2020. Manoj Kumar Panigrahi was appointed as Director on 21 Sep 2020.
Hprime Labs can be reached through the website hprimelabs.com. Its registered office is in Noida, Uttar Pradesh, India.
The registered office of Hprime Labs is at G – 903 9th Floor Maxblis White House Sector – 75, Noida, Uttar Pradesh, India – 201301.
Hprime Labs operates in the healthcare industry, in the diagnostic centers and pathology labs segment.